Results 1 to 10 of about 43,704 (225)

Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia. [PDF]

Cancers (Basel)
Mudd TW, Diebold K, Rangaraju S, Sharma A, Bachiashvili K, Vachhani P, Espinoza-Gutarra MR, Mohty R, Bhatia R, Cortes J, Jamy O.   +10 more
europepmc   +1 more source

Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. [PDF]

Blood Adv
Lee-Miller CA, Kairalla JA, Hibbitts E, Winick NJ, Rabin KR, Angiolillo A, Schore RJ, Salzer WL, Burke MJ, Loh ML, Raetz EA, Hunger SP, Devidas M, Teachey DT, Gupta S, McNeer JL.   +15 more
europepmc   +1 more source

Green TLC-densitometric method for determination of cytarabine and granisetron in spiked human plasma: optimization and whiteness assessment. [PDF]

BMC Chem
Tohamy SI, Abdelaleem EA, Lashien A, Amin MM, Abdelhamid NS.   +4 more
europepmc   +1 more source

Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies. [PDF]

NPJ Precis Oncol
Bevilacqua R, Gasperini P, Cantore T, Macedo-Silva C, Pancher M, Radić M, Yue H, Quaini O, Fedrizzi T, Gatto P, Seiler R, Kiss B, Adami V, Lorenzin F, Kruithof-de Julio M, Faltas BM, Demichelis F.   +16 more
europepmc   +1 more source

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML. [PDF]

Blood Cancer J
Swain RN, Jain A, Wadhera S, Singh C, Jandial A, Khadwal A, Sachdeva MU, Naseem S, Malhotra P, Prakash G.   +9 more
europepmc   +1 more source

Case Report: Iliac perivascular myeloid sarcoma presenting with iliofemoral deep vein thrombosis and hydronephrosis. [PDF]

Front Oncol
Shan Z, Wang Y, Wang H, He J, Cai H.
europepmc   +1 more source

Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations. [PDF]

Cureus
Sapkota S, Alshaikhli A, Shah N, Nepal A, Kulkarni A, Bhandari P, Sapkota S, Kenmoe J, Bayya M, Shrotriya S, Sharma S.   +10 more
europepmc   +1 more source

Translating advances in primary central nervous system lymphoma: from prognostic stratification to treatment innovation. [PDF]

Front Oncol
Pan Z, Bao J, Wei S.
europepmc   +1 more source

2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis. [PDF]

Ann Hematol
Liu N, Ma YR, Pang JN, Sun M-, Sun Y, Liu YJ, Hu JW, Li YH, Qiao ZQ, Duan MH, Gao SJ, Jiang Q, Hu LD.   +12 more
europepmc   +1 more source

Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia. [PDF]

Front Med (Lausanne)
Liu CL, Yan FL, Li XL.
europepmc   +1 more source